Derniers ajouts - Age-Related Macular Degeneration - Dry
|
Reticular pseudodrusenvu 210 fois23 Février 2025
|
|
Reticular pseudodrusenvu 209 fois23 Février 2025
|
|
Reticular pseudodrusenvu 209 fois23 Février 2025
|
|
Reticular pseudodrusenvu 187 fois23 Février 2025
|
|
Reticular pseudodrusenvu 194 fois23 Février 2025
|
|
Reticular pseudodrusenvu 181 fois23 Février 2025
|
|
Reticular pseudodrusenvu 224 fois23 Février 2025
|
|
Reticular pseudodrusenvu 204 fois23 Février 2025
|
|
Reticular pseudodrusenvu 201 fois23 Février 2025
|
|
Reticular pseudodrusenvu 194 fois23 Février 2025
|
|
Reticular pseudodrusenvu 218 fois23 Février 2025
|
|
Reticular pseudodrusenvu 174 fois23 Février 2025
|
|
Reticular pseudodrusenvu 185 fois23 Février 2025
|
|
Reticular pseudodrusenvu 192 fois23 Février 2025
|
|
Reticular pseudodrusenvu 192 fois23 Février 2025
|
|
Reticular pseudodrusenvu 195 fois23 Février 2025
|
|
Reticular pseudodrusenvu 180 fois23 Février 2025
|
|
Reticular pseudodrusenvu 169 fois23 Février 2025
|
|
Reticular pseudodrusenvu 169 fois23 Février 2025
|
|
Reticular pseudodrusenvu 179 fois23 Février 2025
|
|
Reticular pseudodrusenvu 206 fois23 Février 2025
|
|
54 year old female with a lot of drusenvu 191 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 195 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 186 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 189 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 212 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 208 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 195 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
54 year old female with a lot of drusenvu 209 foisVA 20/12 OD, 20/16 OS - no symptoms21 Décembre 2024
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 238 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 244 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 219 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 197 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 234 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 231 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 235 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 224 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Large Hyper-reflective drusen in age-related macular degenerationvu 242 fois69 year old healthy woman with 20/20 vision and no visual complaints22 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 228 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 213 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 214 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 196 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 203 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 236 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 223 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 216 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesionvu 255 fois80 year old female with 20/50 vision in both eyes. Mild blurring17 Septembre 2023
|
|
Optic Disc Melanocytoma - Atypicalvu 336 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 346 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 302 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 317 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 334 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 309 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 314 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 297 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 319 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 338 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Optic Disc Melanocytoma - Atypicalvu 369 fois45 year old female with normal vision and optic nerve lesion in the left eye. VA 20/16 OU. Extensive testing was normal including brain and orbit MRI. The lesion has been stable for 5 years.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 327 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 344 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 314 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 321 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 336 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 324 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 312 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 301 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 281 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Dry AMD - Pigment - AREDS risk score of 4vu 288 fois65 year old woman with 20/32 vision. A little blurred. Pigment and large drusen in each eye. AREDS risk score of four.17 Août 2022
|
|
Soft Drusenvu 337 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 347 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 335 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 325 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 333 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Soft Drusenvu 373 fois63 year old female with 20/16 vision both eyes17 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 353 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 341 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 336 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 356 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 348 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 321 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 359 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 353 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 343 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 382 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 345 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 320 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 351 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 333 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 309 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 346 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 351 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 376 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 373 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 382 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 359 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 356 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 361 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 379 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 341 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
Age-related macular degeneration - Geographic Atrophy - Intermittent CME left eye from CRVO, Anemia, Diabetesvu 395 fois79 year old female - 3 years post CRVO in the left eye (20/32 VA) with intermittent CME. Left eye is the better eye. Vision is stable since 2 years ago
PMHx: Type II DM x 20 years, Chronic Anemia, Hyperlipidemia
VA 20/200 OD, 20/50 OS (usually 20/40)16 Octobre 2021
|
|
| 582 photos sur 6 page(s) |
1 |
 |
|
|
|
